Evidence map›Paper›PMID 26245843›Full record

ArticleChinese journal of cancer2015

Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou, 2000-2011.

Qin Zhou, Ke Li, Guo-Zhen Lin, Ji-Chuan Shen, Hang Dong, Yu-Ting Gu, Hua-Zhang Liu

Open access · goldAbstract read
In one paragraph

Article in Chinese journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qin ZhouDepartment of Biostatistics and Cancer Registration, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510060, P.R. China. cristy_autumnh@126.com.
Ke LiDepartment of Biostatistics and Cancer Registration, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510060, P.R. China. 215301332@qq.com.
Guo-Zhen LinDepartment of Biostatistics and Cancer Registration, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510060, P.R. China. xwkgzcdc@126.com.
Ji-Chuan ShenDepartment of Biostatistics and Cancer Registration, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510060, P.R. China. 346664403@qq.com.
Hang DongDepartment of Biostatistics and Cancer Registration, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510060, P.R. China. 154297026@qq.com.
Yu-Ting GuDepartment of Biostatistics and Cancer Registration, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510060, P.R. China. 879581892@qq.com.
Hua-Zhang LiuDepartment of Biostatistics and Cancer Registration, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, 510060, P.R. China. szk@gzcdc.org.cn.
Centers for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionColorectal cancer (CRC) is the third most common cancer in China. The incidence of CRC has been increasing in recent years. The aim of this study was to explore the incidence trends and the age distribution of CRC by subsite in Guangzhou between 2000 and 2011.

methodsA total of 22,432 incident cases of CRC between 2000 and 2011 from Guangzhou Cancer Registry were identified. Crude incidence and age-standardized rates (ASRs), using the Segi's world standard population, were calculated for CRC and CRC subsites. The incidence trend was analyzed and the annual percentage change (APC) in incidence was calculated by using JoinPoint software.

resultsThe crude incidence increased significantly from 23.4/10(5) in 2000 to 37.4/10(5) in 2011 for males and from 20.9/10(5) to 30.5/10(5) for females. The ASRs of CRC incidence stabilized during the period of 2000-2011 for both males and females. The ages at the onset of CRC for both males and females during 2010-2011 were significantly higher compared with those during 2000-2002 (males: t = 1.95, P = 0.05; females: t = 6.03, P < 0.01). For males aged 50-64 years, the CRC incidence increased by 8.50% annually (P = 0.04) during 2000-2004 and by 1.68% annually (P = 0.03) during 2005-2011. For females aged 65 years and older, the CRC incidence increased by 5.77% annually (P = 0.03) during 2000-2004. There were no significant changes for the CRC incidences in males aged 49 and younger and 65 years and older and females aged 64 years and younger during 2000-2004, or for those in all females as well as males aged 49 years and younger and 65 years and older during 2005-2011. The percentage of colon cancer in all CRCs increased significantly for both males and females between the periods of 2000-2002 and 2010-2011. The ASRs of descending colon and sigmoid colon cancer incidences increased significantly for females during 2005-2011 (APC, 5.51% and 1.08%, respectively, both P < 0.05).

conclusionsThe crude incidence of CRC increased significantly between 2000 and 2011 because of the aging, whereas the ASRs kept stable. The percentage of colon cancer in all CRCs increased significantly. Further surveillance, research, and intervention are needed to identify the causes of these changes and to reduce the incidence and mortality of CRC.

Indexed as

Age DistributionColorectal NeoplasmsIncidenceAgingChinaFemaleHumansMaleSigmoid Neoplasms

Identifiers

PMID26245843
PMCPMC4593365
OpenAlexW1613027111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.